David A. Finkelstein
Oprichter bij Path Systems, Inc.
Profiel
David A.
Finkelstein has been Chief Strategy Officer of Interleukin Genetics, Inc. since August 17, 2006.
Prior to joining Interleukin, he had been Chief Operating Officer and Founder of the Alan James Group LLC since 2002.
Prior to founding Alan James Group, Mr. Finkelstein was the Founder of Fusive.com Corp.
He received a BSME from the University of Vermont and an MBA from York University, Toronto, Canada.
Actieve functies van David A. Finkelstein
| Bedrijven | Functie | Begin |
|---|---|---|
| Path Systems, Inc. | Oprichter | 03-06-2010 |
| Reference Media Corp. | Oprichter | 03-06-2010 |
Eerdere bekende functies van David A. Finkelstein
| Bedrijven | Functie | Einde |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 02-07-2007 |
Opleiding van David A. Finkelstein
| University of Vermont | Undergraduate Degree |
| York University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
| Path Systems, Inc. | |
| Reference Media Corp. |
